| The use of vaginal misoprostol for second-trimester pregnancy termination in women with previous single cesarean section. | |
| | |
MedLine Citation:
|
PMID: 16982234 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
INTRODUCTION: This retrospective study reports of 85 women in the second trimester with one prior cesarean section undergoing medical abortion of a viable unwanted pregnancy using vaginal misoprostol. Two regimens that were selected in a nonrandomized manner were used. MATERIALS AND METHODS: Eighty-five women treated with vaginal misoprostol in a 3-year period were retrospectively analyzed. All received 400 mug of misoprostol initially and 22 (25.8%) aborted. Then Group A (n=43) received subsequent administration of 200 microg every 6 h, whereas Group B (n=20) received 400 microg/6 h. RESULTS: All patients aborted. The groups had no statistical difference in mean age, gravidity, parity, gestational age, and time from previous cesarean section, and there was no difference in occurrence of side effects and mean induction to abortion time interval. The lower dosage group received a median of 600 microg of vaginal misoprostol (min 600 microg to max 1000 microg). There were no uterine ruptures, need for hysterotomy, or excess bleeding in any patient. CONCLUSIONS: This is the largest series reported to date of second-trimester pregnancy termination in cases with one previous cesarean section using only vaginal misoprostol. The study shows that both used regimens are safe and equally effective. All 85 women aborted. |
| | |
Authors:
|
Alexandros Daponte; Guy Nzewenga; Konstantinos D Dimopoulos; Franco Guidozzi |
Related Documents
:
|
4033154 - Speculations on the origin of the ill-effects associated with the use of visual display... 8513674 - Midtrimester induction of abortion: comparison of extraovular prostaglandin e2 and intr... 11574654 - Screening for disability: a eugenic pursuit? 7199914 - Pregnancy termination in dogs with novel non-hormonal compounds. studies of 2-(3-ethoxy... 17094044 - Relationship between intertwin delivery interval and metabolic acidosis in the second t... 6698214 - Culture factors in relation to the success of human in vitro fertilization and embryo t... |
Publication Detail:
|
Type: Comparative Study; Evaluation Studies; Journal Article Date: 2006-05-12 |
Journal Detail:
|
Title: Contraception Volume: 74 ISSN: 0010-7824 ISO Abbreviation: Contraception Publication Date: 2006 Oct |
Date Detail:
|
Created Date: 2006-09-19 Completed Date: 2007-02-07 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0234361 Medline TA: Contraception Country: United States |
Other Details:
|
Languages: eng Pagination: 324-7 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynaecology, University Hospital of Larissa, University of Thessalia, Larissa 41110, Greece. dapontea@otenet.gr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abortifacient Agents, Nonsteroidal
/
administration & dosage Abortion, Induced / methods* Administration, Intravaginal Adolescent Adult Cesarean Section* Dose-Response Relationship, Drug Female Gestational Age Gravidity Humans Misoprostol / administration & dosage* Parity Pregnancy Pregnancy Trimester, Second / drug effects* Retrospective Studies Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Abortifacient Agents, Nonsteroidal; 59122-46-2/Misoprostol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Utilization of contraception and abortion and its relationship to HIV infection among female sex wor...
Next Document: Sublingual versus vaginal misoprostol (400 microg) for cervical priming in first-trimester abortion:...